All In Biotech

Drug Trial Radar · NCT00768599

A Study of Econazole Foam 1% in Athlete's Foot

A Multi-Center Randomized, Evaluator-Blinded, Vehicle Controlled, Parallel Group Comparison Study of the Safety and Efficacy of Econazole Nitrate Foam 1%, Econazole Nitrate 1% Cream, and Foam Vehicle in Subjects With Tinea Pedis

Last checked: Nov 19, 2026Latest source record: Jan 9, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 135 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

135

Actual

Start

Mar 2008

Primary completion

Sep 2008

Study completion Oct 2008

Sponsor

Lead sponsor
AmDermaIndustry
Sponsor type
Industry
First posted
Oct 8, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a 6-week clinical study (4 weeks of treatment, once per day, plus a 2-week follow-up period) of a topical foam to treat athlete's foot. The active ingredient in the foam -- econazole nitrate 1% -- is the same active pharmaceutical ingredient in a cream that your doctor can currently prescribe to treat athlete's foot. This study will help to understand if the foam works the same as the cream to treat athlete's foot.

Conditions

  • Tinea Pedis
  • Athlete's Foot

Interventions

  • Econazole Nitrate Cream 1%Drug

    Topical cream, applied once daily for 4 weeks.

  • Econazole Nitrate Foam 1%Drug

    Topical foam, applied once daily for 4 weeks.

  • Vehicle FoamDrug

    Topical foam, applied once daily for 4 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Complete Cure Rate: Interdigital DiseaseTime frame: Day 43
  2. Complete Cure Rate: Moccasin DiseaseTime frame: 43 Days

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Stacy Smith, MD

    San Diego, California

  • Daniel Stewart, DO

    Clinton Township, Michigan

  • Steven Kempers, MD

    Fridley, Minnesota

  • Michael Gold, MD

    Nashville, Tennessee

  • Michael Jarratt, MD

    Austin, Texas

  • Leonard Swinyer, MD

    Salt Lake City, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.